BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/23/2021 7:48:08 AM | Browse: 621 | Download: 1108
 |
Received |
|
2021-02-28 11:57 |
|
Peer-Review Started |
|
2021-02-28 12:06 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-05-01 17:23 |
|
Revised |
|
2021-05-10 12:53 |
|
Second Decision |
|
2021-08-13 02:57 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-08-13 07:12 |
|
Articles in Press |
|
2021-08-13 07:12 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-08-25 08:13 |
|
Typeset the Manuscript |
|
2021-09-17 10:30 |
|
Publish the Manuscript Online |
|
2021-09-23 07:48 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Edina Amponsah-Dacosta |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| The Harry Crossley Postdoctoral Research Fellowship 2021 |
|
|
| Corresponding Author |
Edina Amponsah-Dacosta, PhD, Postdoctoral Fellow, Vaccines for Africa Initiative, School of Public Health and Family Medicine, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, Western Cape, South Africa. edina.amponsah-dacosta@uct.ac.za |
| Key Words |
Hepatitis B virus; Viral hepatitis, Hepatocellular Carcinoma; Elimination; Human Immunodeficiency Virus; Sub-Saharan Africa |
| Core Tip |
Chronic hepatitis B virus (HBV) infection is the primary risk factor for hepatocellular carcinoma (HCC) in sub-Saharan Africa. In 2020, HBV-associated HCC accounted for approximately 36700 deaths. By 2040, it is projected that approximately 72200 people will die each year from this disease without an intensive public health response. The high mortality-to-incidence ratio associated with HCC in sub-Saharan Africa suggests significant inequities in access to appropriate health care. This review scopes the evidence on the extent of the disease burden in sub-Saharan Africa and advocates for prioritizing HCC control as part of ongoing viral hepatitis elimination strategies within this region. |
| Publish Date |
2021-09-23 07:48 |
| Citation |
Amponsah-Dacosta E. Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030? World J Gastroenterol 2021; 27(36): 6025-6038 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i36/6025.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i36.6025 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
